Meet Prof. Smita Pattanaik: Pioneer in Pharmacology Research

Prof. Smita Pattanaik, MD, DM, is a distinguished figure in the field of Pharmacology, currently serving as a Professor at the esteemed Department of Pharmacology, PGIMER, Chandigarh. With her extensive academic background and professional experience, Prof. Pattanaik has established herself as a leader in pharmacokinetic (PK) and pharmacodynamic (PD) studies.

About Prof. Pattanaik: Prof. Smita Pattanaik obtained her MD, DM degrees from the Department of Pharmacology, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh. As a Fulbright-Nehru academic and professional excellence fellow, she received specialized training in Emory clinical and translational research laboratory at Emory University School of Medicine, Atlanta, GA, USA.

Woman

Prof. Pattanaik's expertise lies in conducting PK and PD studies on routine immunosuppressant drugs for organ transplantation and SLE treatment. Additionally, her lab actively collaborates with the Department of Urology at PGIMER to develop novel anticancer drug repurposing strategies in genitourinary cancers. Her current focus is on devising innovative formulation strategies for clinically important drugs, aiming to significantly benefit patients. Proficient in clinical trial design, Prof. Pattanaik has played a pivotal role in introducing Therapeutic Drug Monitoring (TDM) services in the Department of Pharmacology, enhancing routine patient care standards.

Shape About About
Shape About Shape

About lab

Welcome to our lab, we are located in the PGIMER, Chandigarh

At our forefront, we conduct ground breaking research in two pivotal realms: Pharmacokinetic (PK) and Pharmacodynamic (PD) studies of standard immunosuppressant drugs for organ transplantation, and the repurposing of anti-cancer medications. Our core mission is to bridge the gap between laboratory insights and real-world impact by translating our findings into clinical trials. Ultimately, our aim is to revolutionize patient care in these critical areas of healthcare.

Read More
Shape Bg Shape Shape Shape

Team member and collaborators

Current team members

Team

Sumit Dey

PhD Scholar, DBT Fellow

Specializing in bladder cancer research. With a focus on drug repurposing, Mr. Dey aims to explore the potential of repurposing anticancer drugs to treat bladder cancer. His innovative research approach holds promise for identifying new therapeutic options and improving outcomes for patients with this challenging disease.

Team

Sheetal Singh

PhD Scholar, CSIR-UGC fellow

Specializing in renal cell carcinoma research. With a primary focus on drug repurposing, she aims to investigate the potential of repurposing anticancer drugs for the treatment of renal cancers. Her research endeavors hold promise for identifying innovative therapeutic approaches and improving outcomes for patients with clear cell carcinoma.

Team

Ritika

PhD Scholar, ICMR-SRF

Dedicated PhD scholar and ICMR fellow specializing in renal transplantation research. Her current research focuses on identifying pharmacodynamic biomarkers involved in renal transplantation patients, a critical aspect of successful renal transplantation. Through her meticulous investigations, Ms. Ritika aims to enhance our understanding of the immune response in transplant patients, ultimately leading to improved patient outcomes and personalized immunosuppressive strategies.

View all
Shape Bg Shape Shape Shape

Alumni team members

Team

Priyanka Naithani

PhD (2017-2022)

Priyanka, an esteemed alumni who has conducted research on the pharmacogenomics of renal transplantation patients. With a focus on personalized medicine, she explored the genetic factors influencing drug response and toxicity in the context of renal transplantation. Her work has contributed to the understanding of individualized treatment approaches, optimizing drug selection and dosing strategies to improve patient outcomes and minimize adverse effects.

Team

Neeru Sharma

M.Sc (2019-2021)
Current status: Pharmacist AAMC,Patiala

MSc student from 2019 to 2021, Neeru dedicated her studies to developing an animal model of bladder cancer as part of her MSc dissertation. Not only did she successfully create the model, but she also explored innovative treatments for bladder cancer within her research.

Team

Neha Dhir

M.Sc (2014-2016)
Current status: PhD from PGIMER

made significant contributions to the field of neuroscience, with a specialization in Aneurysmal Subarachnoid Haemorrhage (aSAH). Her MSc dissertation focused on in-depth research and analysis of this complex neurological disorder. Neha has since completed her PhD, further expanding her expertise in the field of neuroscience. Her continued dedication to research and education demonstrates her unwavering commitment to advancing scientific knowledge and making a positive impact in the medical community.

View all
Shape Bg Shape Shape Shape

Collaborators

Team

Dr. Savita Verma Attri

Professor Department of Biochemistry PGIMER

Team

Dr. Shalmoli Bhattacharyya

Professor and Head Department of Biophysics PGIMER

Team

Dr. Jean-Baptiste Woillard

Associate Professor Centre Hospitalier Universitaire de Limoges,France

View all

Gallery

ProjectProjectProjectProjectProjectProjectProjectProject
ProjectProjectProjectProjectProjectProject
ProjectProjectProjectProjectProjectProjectProject

Lab News

Breaking Lab News: Exploring the Lab Discoveries

Quote

Dr. Smita Pattanaik became the Associate Editor of the journal ‘Trials’ in 2023

Read More
Shape About About
Shape About Shape

Achievements

List of publications

Shape Shape Shape Shape Shape

Let’s Stay Connected

Shape Shape

Office Location

Lab 4030, Department of Pharmacology, Research Block B, PGIMER, Chandigarh.

Phone Number

+91-9417724464

Social Media


Bg Shape

Collaborate for innovative pharmacology and better patient care.

If you are passionate about translational pharmacology and wish to contribute to ground-breaking research, we welcome collaborations, partnerships, and talented individuals to join our team. Together, we can drive innovation and make a significant impact on drug discovery and development.